PetMed Express (PETS) Scheduled to Post Quarterly Earnings on Wednesday

PetMed Express (NASDAQ:PETS) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.30. The business had revenue of $67.95 million for the quarter, compared to the consensus estimate of $77.52 million. PetMed Express had a negative return on equity of 3.44% and a negative net margin of 1.24%. On average, analysts expect PetMed Express to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

PetMed Express Price Performance

PETS stock opened at $4.08 on Wednesday. PetMed Express has a 1-year low of $2.90 and a 1-year high of $9.45. The business has a 50-day moving average price of $3.61 and a 200 day moving average price of $3.87. The company has a market capitalization of $84.05 million, a P/E ratio of -24.00 and a beta of 0.71.

Insider Transactions at PetMed Express

In related news, major shareholder Nina Capital Holdings Inc. acquired 12,500 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were bought at an average price of $3.34 per share, with a total value of $41,750.00. Following the completion of the transaction, the insider now directly owns 2,078,000 shares in the company, valued at $6,940,520. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.10% of the company’s stock.

Analyst Ratings Changes

Separately, Lake Street Capital reaffirmed a “hold” rating and issued a $3.50 price target (down previously from $7.00) on shares of PetMed Express in a research report on Wednesday, August 7th.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.